Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/RVX_208> ?p ?o }
Showing triples 1 to 59 of
59
with 100 triples per page.
- RVX_208 abstract "RVX 208 (RVX-208) is an orally available small molecule created by Resverlogix Corp. that is being evaluated in clinical trials for the treatment of atherosclerosis and associated cardiovascular disease (CVD). In two phase II clinical trials in patients with established CVD, RVX-208 increased HDL-cholesterol (HDL-c) and apolipoprotein A-I (ApoA-I) levels, as well as decreased the incidence of major adverse cardiac events (MACE). Reduction of MACE was accentuated in patients with diabetes mellitus.".
- RVX_208 iupacName "2-[4-(2-Hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxy-4(3H)-quinazolinone".
- RVX_208 thumbnail RVX-208.svg?width=300.
- RVX_208 wikiPageID "43728015".
- RVX_208 wikiPageLength "8624".
- RVX_208 wikiPageOutDegree "33".
- RVX_208 wikiPageRevisionID "673001435".
- RVX_208 wikiPageWikiLink Acetylated_lysine.
- RVX_208 wikiPageWikiLink Acetyllysine.
- RVX_208 wikiPageWikiLink Apolipoprotein_A-I.
- RVX_208 wikiPageWikiLink Apolipoprotein_A1.
- RVX_208 wikiPageWikiLink Artery.
- RVX_208 wikiPageWikiLink Atheroma.
- RVX_208 wikiPageWikiLink Atherosclerosis.
- RVX_208 wikiPageWikiLink Atherosclerotic_plaque.
- RVX_208 wikiPageWikiLink BET_inhibitor.
- RVX_208 wikiPageWikiLink BRD4.
- RVX_208 wikiPageWikiLink Bromodomain.
- RVX_208 wikiPageWikiLink Cardiovascular_disease.
- RVX_208 wikiPageWikiLink Category:Primary_alcohols.
- RVX_208 wikiPageWikiLink Category:Quinazolinones.
- RVX_208 wikiPageWikiLink Cholesterol.
- RVX_208 wikiPageWikiLink Clinical_trial.
- RVX_208 wikiPageWikiLink Clinical_trials.
- RVX_208 wikiPageWikiLink DNA.
- RVX_208 wikiPageWikiLink Excretion.
- RVX_208 wikiPageWikiLink Gene_expression.
- RVX_208 wikiPageWikiLink HDL.
- RVX_208 wikiPageWikiLink High-density_lipoprotein.
- RVX_208 wikiPageWikiLink Histone.
- RVX_208 wikiPageWikiLink Inflammation.
- RVX_208 wikiPageWikiLink Liver.
- RVX_208 wikiPageWikiLink Reverse_cholesterol_transport.
- RVX_208 wikiPageWikiLink Transcription_(genetics).
- RVX_208 wikiPageWikiLinkText "RVX 208".
- RVX_208 wikiPageWikiLinkText "RVX-208".
- RVX_208 hasPhotoCollection RVX_208.
- RVX_208 imagefile "RVX-208.svg".
- RVX_208 iupacname "2".
- RVX_208 name "RVX 208".
- RVX_208 othernames "RVX208, RVX-208".
- RVX_208 wikiPageUsesTemplate Template:Chembox.
- RVX_208 wikiPageUsesTemplate Template:Orphan.
- RVX_208 wikiPageUsesTemplate Template:Pharma-stub.
- RVX_208 wikiPageUsesTemplate Template:Reflist.
- RVX_208 subject Category:Primary_alcohols.
- RVX_208 subject Category:Quinazolinones.
- RVX_208 type ChemicalCompound.
- RVX_208 type ChemicalSubstance.
- RVX_208 type ChemicalObject.
- RVX_208 type Thing.
- RVX_208 type Q11173.
- RVX_208 comment "RVX 208 (RVX-208) is an orally available small molecule created by Resverlogix Corp. that is being evaluated in clinical trials for the treatment of atherosclerosis and associated cardiovascular disease (CVD). In two phase II clinical trials in patients with established CVD, RVX-208 increased HDL-cholesterol (HDL-c) and apolipoprotein A-I (ApoA-I) levels, as well as decreased the incidence of major adverse cardiac events (MACE).".
- RVX_208 label "RVX 208".
- RVX_208 sameAs m.011spkdg.
- RVX_208 wasDerivedFrom RVX_208?oldid=673001435.
- RVX_208 depiction RVX-208.svg.
- RVX_208 isPrimaryTopicOf RVX_208.
- RVX_208 name "RVX 208".